文献速递认知障碍与痴呆帕金森病与运动障碍

突触核蛋白病认知前驱期脑-临床模式

A Prodromal Brain-Clinical Pattern of Cognition in Synucleinopathies.
PubMed 文献 · Ann Neurol · 2020-12-07

研究在48例iRBD患者中识别脑-临床特征,并在78例纵向随访iRBD中验证其预测突触核蛋白病转化。该特征可预测iRBD转化为DLB(OR=4.754),而非PD,且与PD患者1、2、4年认知表现相关。

要点

  • 脑-临床变形评分可预测iRBD向DLB转化。
  • 该评分不能预测iRBD向PD转化。
  • 评分与PD患者1、2、4年认知表现相关。

核心结论

  • 识别出一种脑-临床特征,可预测iRBD向更严重/痴呆型突触核蛋白病转化。

研究设计与样本

  • 在48例多导睡眠图确诊的iRBD患者中,采用偏最小二乘法分析脑变形与27个临床变量的关系。
  • 将所得变量应用于78例纵向随访的iRBD患者,预测突触核蛋白病转化。
  • 将iRBD患者的变形评分与207例PD、DLB或前驱期DLB患者比较。

主要发现

  • 一个潜变量解释了iRBD中31%的脑-临床协方差,结合皮质和皮质下变形及蛛网膜下腔/脑室扩张与认知和运动变量。
  • 该特征的变形评分预测iRBD向突触核蛋白病转化(p=0.036,OR=2.249;95%CI=1.053-4.803)。
  • 变形评分预测向DLB转化(OR=4.754;95%CI=1.283-17.618,p=0.020),不预测向PD转化(p=0.286)。
  • 发展为痴呆的iRBD患者评分与临床和前驱期DLB患者相似,但高于PD患者。
  • 变形评分还预测PD患者1、2、4年的认知表现。

临床怎么用

  • 该脑-临床特征或可作为生物标志物,用于优化患者管理、靶向风险降低策略和实施神经保护试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Isolated (or idiopathic) rapid eye movement sleep behavior disorder (iRBD) is associated with dementia with Lewy bodies (DLB) and Parkinson's disease (PD). Biomarkers are lacking to predict conversion to a dementia or a motor-first phenotype. Here, we aimed at identifying a brain-clinical signature that predicts dementia in iRBD. METHODS: A brain-clinical signature was identified in 48 patients with polysomnography-confirmed iRBD using partial least squares between brain deformation and 27 clinical variables. The resulting variable was applied to 78 patients with iRBD followed longitudinally to predict conversion to a synucleinopathy, specifically DLB. The deformation scores from patients with iRBD were compared with 207 patients with PD, DLB, or prodromal DLB to assess if scores were higher in DLB compared to PD. RESULTS: One latent variable explained 31% of the brain-clinical covariance in iRBD, combining cortical and subcortical deformation and subarachnoid/ventricular expansion to cognitive and motor variables. The deformation score of this signature predicted conversion to a synucleinopathy in iRBD (p = 0.036, odds ratio [OR] = 2.249; 95% confidence interval [CI] = 1.053-4.803), specifically to DLB (OR = 4.754; 95% CI = 1.283-17.618, p = 0.020) and not PD (p = 0.286). Patients with iRBD who developed dementia had scores similar to clinical and prodromal patients with DLB but higher scores compared with patients with PD. The deformation score also predicted cognitive performance over 1, 2, and 4 years in patients with PD. INTERPRETATION: We identified a brain-clinical signature that predicts conversion in iRBD to more severe/dementing forms of synucleinopathy. This pattern may serve as a new biomarker to optimize patient care, target risk reduction strategies, and administer neuroprotective trials. ANN NEUROL 2021;89:341-357.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Rahayel S, Postuma RB, Montplaisir J, et al. A Prodromal Brain-Clinical Pattern of Cognition in Synucleinopathies. Ann Neurol. 2020. PMID: 33217037. doi:10.1002/ana.25962

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。